{
    "code": "02004359",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02004359",
    "time": "2019-03-01 03:05:58",
    "許可證字號": "衛署藥輸字第004359號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/06\/21",
    "發證日期": "97\/06\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "立舒定錠6毫克",
    "英文品名": "LEXOTAN TABLETS 6MG",
    "適應症": "焦慮狀態",
    "劑型": "110錠劑",
    "包裝": "2-1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "BROMAZEPAM"
    ],
    "限制項目": "1Q不得輸入 34第四級管制藥品",
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250463100  Delpharm Milano S.r.l.",
        "製造廠廠址": "VIA Carnevale, 1-20090 SEGRATE (MI), ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F430093000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "GRENZACHERSTRASSE 124, CH-4070 BASEL,SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2824200100",
            "成分名稱": "BROMAZEPAM",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lexotan_CDS8.0_Delpharm_reformat_1118-LEX-02_(150x304.5mm)_排-108-01-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004359&Seq=012&Type=9"
        },
        {
            "title": "Lexotan_CDS 8.0_CMS Delpharm_1118-LEX-01_(150x304.5mm)_排-108-01-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004359&Seq=011&Type=9"
        },
        {
            "title": "20170817_response 2_CTN_6 mg-106-08-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004359&Seq=005&Type=8"
        },
        {
            "title": "20170817_response 2_Blister_6mg-106-08-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004359&Seq=004&Type=8"
        }
    ]
}